Pharma policy crippling the industry

The Indian pharma sector is currently grappling with a number of issues which need speedy resolution. Regulatory delay in clinical trials is an issue impacting the pharma industry in a big way. The delays have severely derailed the innovation curve and also the growth of the clinical trial industry. Ineffective regulatory oversight, need for safeguards for informed consent for vulnerable populations and compensation guidelines for patients have emerged as major concerns. 

Read Full Story>>